NASDAQ: RYZB - RayzeBio, Inc. Common Stock

半年間の収益性: 0%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール RayzeBio, Inc. Common Stock

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について RayzeBio, Inc. Common Stock

RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company's lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs).

さらに詳しく
It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 2023-09-14
ISIN US75525N1072
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://rayzebio.com
Цена ао 62.49
1日あたりの価格変動: 0% (62.49)
週ごとの価格変動: 0% (62.49)
月ごとの料金変更: 0% (62.49)
3ヶ月間の価格変動: 0% (62.49)
半年間の価格変動: 0% (62.49)
年間の価格変動: 0% (62.49)
年初からの価格変動: 0% (62.49)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
合計: 2.5

効率

名前 意味 学年
ROA, % 0 0
ROE, % 0 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA 0 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % 0 0
収益性 Ebitda, % 953.57 10
収益性 EPS, % 2126.11 10
合計: 8
さらに詳しく

機関 音量 共有, %
Viking Global Investors, L.P. 6642700 11.09
venBio Partners LLC 5158162 8.61
Versant Venture Management, LLC 5158161 8.61
VR Adviser, LLC 4030471 6.73
Wellington Management Group, LLP 3504409 5.85
Sofinnova Investments, Inc. 2419528 4.04
Orbimed Advisors LLC. 2365213 3.95
Redmile Group, LLC 1857706 3.1
Samsara BioCapital, LLC 1845948 3.08
Blackrock Inc. 1368838 2.28



スーパーバイザー 役職 支払い 生年
Dr. Kenneth Song M.D. President, CEO & Director 646k 1975 (50 年)
Mr. Arvind Kush Chief Financial Officer 714.76k 1983 (42 年)
Dr. Susan Moran M.D. Chief Medical Officer 559.84k 1969 (56 年)
Mr. Aron Marc Knickerbocker Co-Founder N/A 1969 (56 年)
Mr. Jeff Woodley General Counsel N/A
Mr. Eric Bischoff Senior Vice President of Development & Operations N/A
Dr. Gary G. Li Ph.D. Senior Vice President of Biology & Translational Medicine N/A
Ms. Kimberly Ma M.S. Senior Vice President of Clinical Operations N/A
Dr. Nicholas D. Smith Ph.D. Senior Vice President of Chemistry Innovation N/A
Mr. Abhi Bhat Ph.D. Senior VP of Chemistry & Head of Discovery N/A

住所: United States, San Diego. CA, 5505 Morehouse Drive - Googleマップで開く, Yandexマップを開く
Webサイト: https://rayzebio.com